NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Market Update

March 16, 2024

The Indian equity market experienced a sharp downtrend for the third consecutive session, with a decline of 2%. The Strait of Hormuz crisis has pushed oil prices higher, leading to a negative bias in the market. Market breadth remained weak, with 2,551 shares declining against 420 advancing shares on the National Stock Exchange (NSE).

Short-term Trading Ideas

Read also: Expert Portfolio Manager Raja Venkatraman Names Top Investment Picks for June 4

NTPC Green Energy

  • CMP: Rs 98.15
  • Strategy: Buy
  • Target: Rs 110, Rs 115
  • Stop-Loss: Rs 85

NTPC Green Energy has shown a significant rebound from its lifetime low zone and has surged above all its significant Exponential Moving Averages (EMAs) on the daily chart. The MACD histogram also portrays a bullish reversal signal on the daily timeframe.

Tata Power Company

Read also: MarketSmith India's 4 June Stock Recommendations

  • CMP: Rs 395
  • Strategy: Buy
  • Target: Rs 415, Rs 420
  • Stop-Loss: Rs 375

Tata Power has demonstrated strong buying traction in the last couple of weeks, propelling the counter above all its significant EMAs with multiple positive crossovers.

Federal Bank

  • CMP: Rs 263
  • Strategy: Sell
  • Target: Rs 250, Rs 240
  • Stop-Loss: Rs 273

Federal Bank is showing signs of a short-term trend reversal, with bearish sentiment prevailing. The stock remains below its 20-, 50-, and 100-day Simple Moving Averages (SMAs), reinforcing the ongoing downtrend.

JB Chemicals and Pharmaceuticals

  • CMP: Rs 2,121.8
  • Strategy: Buy
  • Target: Rs 2,200, Rs 2,300
  • Stop-Loss: Rs 2,070

JB Chemicals has made a decisive move above multiple resistance levels, bolstered by high trading volume. The stock has received buy signals from both weekly and monthly Bollinger Bands, indicating rising momentum.

Sterlite Technologies

  • CMP: Rs 187
  • Strategy: Buy
  • Target: Rs 200, Rs 230
  • Stop-Loss: Rs 175

Sterlite Technologies is exhibiting a robust uptrend, characterized by a series of higher highs and higher lows, indicating a positive bias in the market.

Ajanta Pharma

  • CMP: Rs 3,030.6
  • Strategy: Buy
  • Target: Rs 3,415
  • Stop-Loss: Rs 2,950

Ajanta Pharma is displaying strong technical leadership, with the weekly RSI firmly above 60, indicating sustained momentum rather than exhaustion. The stock recently confirmed a breakout from a 29-week cup-and-handle pattern, reinforcing a bullish continuation setup.

Lumax Auto Technologies

  • CMP: Rs 1,434
  • Strategy: Buy
  • Target: Rs 1,500
  • Stop-Loss: Rs 1,350

Lumax Auto Technologies has completed a textbook gap fill near the 1,400 zone and staged a sharp recovery with a large bullish candle and a pronounced lower wick, signaling that weak hands have exited the market.

Investor Takeaway

Consider buying NTPC Green Energy due to its technical rebound and bullish reversal signal.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.